Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
The American Journal on Addictions|April 8, 2015
Spreading the word: A process evaluation of a voluntary AOD prevention programMaria Orlando Edelen, Joan Tucker, Elizabeth D'AmicoHealth & Social Care in the Community|September 15, 2023
The association between housing stability and perceived quality of life among emerging adults with a history of homelessnessAlina I Palimaru, Keisha McDonald, Rick Garvey, et al.Children and Youth Services Review|October 1, 2025
Perceptions from emerging adults with a history of homelessness on their experiences with housing, health and other support servicesKeisha McDonald, Alina I Palimaru, Rick Garvey, et al.Primary Health Care : Open Access|October 14, 2014
Depression and Health Risk Behaviors: Towards Optimizing Primary Care Service Strategies for Addressing RiskJoan Rosenbaum Asarnow, Luis Roberto Zeledon, Elizabeth D'Amico, et al.Frontiers in Psychiatry|May 14, 2023
Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive-compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trialTerence H W Ching, Rachael Grazioplene, Calvin Bohner, et al.Prevention Science : the Official Journal of the Society for Prevention Research|August 1, 2023
Including Community Partners in the Development and Adaptation of Intervention Strategies to Prevent Initiation or Escalation of Opioid MisuseRebecca Perry, Elvira Elek, Elizabeth D'Amico, et al.Frontiers in Psychiatry|January 24, 2024
Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratingsTerence H W Ching, Lucia Amoroso, Calvin Bohner, et al.Frontiers in Psychiatry|March 4, 2024
Corrigendum: Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratingsTerence H W Ching, Lucia Amoroso, Calvin Bohner, et al.Pageof 1